The global peptide therapeutics market was valued at nearly $50 billion in 2024, and its projected to reach up to around $84 billion by 2034.1 One of the most well-known peptides in recent years is semaglutide (Ozempic), a glucagon-like peptide-1 receptor agonist (GLP-1) used for the treatment of type 2 diabetes.2 However, semaglutide is just one of many different peptides that could potentially lead to health benefits
This arm of the mechanism is also believed to drive PCSK9 degradation, which appears to lower LDL cholesterol in clinical readouts
Medications for treating these disorders cannot improve brain function if neurons do not have the building blocks needed to make neurotransmitters such as serotonin or make the proper fats for myelin
Understanding these causes is essential for appropriate clinical management and avoiding unnecessary alarm
Supports neurotransmitter synthesis, is anti-inflammatory, and is especially useful for mood disorders, depression, dementia, PMS, skin disorders, and neuropathy